Skip to content

Wearables in Psychiatry: Assessment of Mood, Activity, and Sleep Using Psychiatric Measurement Instruments and Wearables

Wearables in Psychiatry: Assessment of Mood, Activity, and Sleep Using Psychiatric Measurement Instruments and Wearables - AWEAR-PSY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00040854
Enrollment
30
Registered
2026-07-03
Start date
2026-07-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presence of an affective disorder (e.g., depressive or bipolar episode) according to the treating clinic

Interventions

Group 1: The subject of the study is the prospective collection and analysis of actively assessed affective symptomatology and passively collected digital biomarkers via wearables (e.g., Apple Watch)

Sponsors

Klinik für Psychiatrie und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Minimum age = 18 years - Presence of an affective disorder (e.g., depressive or bipolar episode) as diagnosed by the treating clinic - Outpatient connection to the PIA (at least presentation every 3 months) - Capacity to consent - Written informed consent - Technical requirement: possession of a compatible iPhone or suitable device for pairing with the Apple Watch - Willingness to use the wearable regularly and to participate in monthly clinical visits as well as weekly self-assessments

Exclusion criteria

Exclusion criteria: - Withdrawal of consent or termination of participation - Acute risk of harm to self or others (e.g., acute suicidality) - Inpatient psychiatric treatment during the study period - Severe cognitive impairment (e.g., dementia, severe intellectual disability) with relevant limitation of study participation - Insufficient German language skills for informed consent and completion of self-assessments - Severe psychotic symptoms or other clinical conditions that, in the judgment of the treating clinicians, preclude study participation - Lack of technical suitability (e.g., incompatible device) preventing study conduct

Design outcomes

Primary

MeasureTime frame
H1 (Feasibility): Digital biomarkers can be recorded on at least 80 days within a 3-month period, with a minimum of 18h/day (87.5%) of coverage each day, in the routine context of outpatient psychiatric care.

Secondary

MeasureTime frame
H2 (Clinical Validity, exploratory): There are associations between passively collected digital biomarkers (activity, sleep, heart rate, HRV) and the severity of depressive, manic, and psychotic symptoms over time.

Countries

Germany

Contacts

Public ContactStefanie Schreiter

Klinik für Psychiatrie und Psychotherapie

stefanie.schreiter@charite.de+49 30 450 517 095

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026